Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novartis AG (CH:NOVN – Research Report) and Sigma Healthcare Ltd (DE:S5YA – Research Report).
Sigma Healthcare Ltd (DE:S5YA)
In a report issued on March 23, Ross Curran from Macquarie maintained a Sell rating on Sigma Healthcare Ltd, with a price target of A$0.90. The company’s shares closed last Friday at EUR0.70.
According to TipRanks.com, Curran is ranked #3370 out of 8763 analysts.
Sigma Healthcare Ltd has an analyst consensus of Moderate Sell, with a price target consensus of EUR0.63, which is a -10.0% downside from current levels. In a report issued on March 22, Shaw and Partners also downgraded the stock to Sell with a A$1.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
